Hydroxyethyl-Capped Cationic Peptoids for Nucleic Acid Delivery
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for delivering nucleic acids, such as mRNA, face challenges including rapid degradation, poor cellular uptake, and inefficient endosomal escape, leading to suboptimal expression and immune response concerns.
Innovation Solution
The development of hydroxyethyl-capped tertiary amino lipidated cationic peptoids and their complexes with polyanionic compounds, which form stable delivery vehicle compositions that facilitate efficient endocellular delivery of nucleic acids, enhancing expression and immune response elicitation.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If traditional delivery systems (viral vectors, cationic lipid nanoparticles, polycationic polymers) are used, then nucleic acid delivery is achieved, but stability, toxicity, and immune response problems occur
Solution Approach 1:
The invention uses composite lipid-peptoid structures combining ionizable lipid heads with peptoid backbones, creating materials that exhibit both cationic properties for nucleic acid binding and reduced toxicity compared to traditional polycations. The composite structure allows tuning of physicochemical properties to achieve optimal balance between delivery efficiency and biocompatibility.
Solution Approach 2:
The invention modifies key parameters of delivery systems by adjusting lipid-to-peptoid ratios, molecular weights, and structural configurations to optimize the balance between cationic charge density (for nucleic acid binding) and biocompatibility (reduced toxicity and immune response).
2Stability of the object's composition
If fast degradation is prevented, then nucleic acid stability improves, but delivery efficiency may be compromised
Solution Approach 1:
The cationic lipid-peptoid complexes act as intermediary carriers that protect nucleic acids from degradation in circulation while maintaining the ability to interact with cellular components for efficient delivery. The complexes serve as a protective medium that can be temporarily formed and then disassembled to release active nucleic acids intracellularly.
3Productivity
If cellular uptake is improved, then delivery efficiency increases, but endosomal escape may become inefficient
Solution Approach 1:
The invention employs dynamic pH-responsive behavior where the lipid-peptoid complexes exhibit different properties at different pH levels: more stable at physiological pH for circulation, and undergoing structural changes in the acidic endosomal environment to facilitate escape. The ionizable groups protonate in acidic conditions, triggering membrane disruption or pore formation for endosomal escape.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The delivery vehicle compositions demonstrate improved mRNA expression and immune response induction, with stability and low toxicity, effectively overcoming previous delivery limitations.
Implementation Method 1
The delivery vehicle compositions of the disclosure can form an electrostatic interaction between the hydroxyethyl-capped tertiary amino lipidated cationic peptoids of the delivery vehicle composition and a polyanionic compound, such as a nucleic acid, to form a delivery vehicle complex
Data Source
AI summary
The present disclosure provides delivery vehicle compositions comprising hydroxyethyl-capped tertiary amino lipidated cationic peptoids, and complexes of the delivery vehicles with polyanionic compounds, such as nucleic acids. The disclosure further provides methods of making and using the delivery vehicle compositions and complexes, such as for the delivery polyanionic compounds (e.g., nucleic acids) to cells. The disclosure also provides methods of eliciting an immune response with the delivery vehicle complexes of the disclosure.